Recombinant Uncharacterized protein Rv0628c/MT0656 (Rv0628c, MT0656)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Uncharacterized Protein Rv0628c/MT0656

Recombinant Uncharacterized Protein Rv0628c/MT0656, also known as Rv0628c or MT0656, is a protein derived from Mycobacterium tuberculosis or related species. This protein is often produced through recombinant DNA technology, where the gene encoding the protein is inserted into a host organism like Escherichia coli (E. coli) for expression. The recombinant form of this protein is used in various research applications, including studies on tuberculosis and other diseases.

2.1. Expression and Source

  • Expression System: The protein is typically expressed in E. coli, which is a common host for recombinant protein production due to its ease of use and high yield .

  • Source: The gene for Rv0628c/MT0656 is derived from Mycobacterium tuberculosis or closely related species.

2.2. Physical and Chemical Properties

  • Protein Length: The full-length protein consists of 383 amino acids .

  • Tag: Often fused with an N-terminal His tag to facilitate purification .

  • Form: Available as a lyophilized powder .

  • Purity: Greater than 90% as determined by SDS-PAGE .

Research Applications

Recombinant Uncharacterized Protein Rv0628c/MT0656 is primarily used in research settings to study tuberculosis and related diseases. It can be employed in functional assays to investigate protein interactions, cellular responses, and as standards or controls in immunostaining assays.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement. We will accommodate your request whenever possible.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-383
Protein Length
full length protein
Target Names
Rv0628c, MT0656
Target Protein Sequence
MRIGVGVSTAPDVRRAAAEAAAHAREELAGGTPALAVLLGSRSHTDQAVDLLAAVQASVE PAALIGCVAQGIVAGRHELENEPAVAVWLASGPPAETFHLDFVRTGSGALITGYRFDRTA HDLHLLLPDPYSFPSNLLIEHLNTDLPGTTVVGGVVSGGRRRGDTRLFRDRDVLTSGLVG VRLPGAHSVSVVSQGCRPIGEPYIVTGADGAVITELGGRPPLHRLREIVLGMAPDEQELV SRGLQIGIVVDEHLAVPGQGDFLIRGLLGADPTTGAIGIGEVVEVGATVQFQVRDAAAAD KDLRLAVERAAAELPGPPVGGLLFTCNGRGRRMFGVTDHDASTIEDLLGGIPLAGFFAAG EIGPVAGHNALHGFTASMALFVD
Uniprot No.

Q&A

What are the optimal storage conditions for Recombinant Uncharacterized protein Rv0628c/MT0656?

For maximum stability and activity preservation, Recombinant Uncharacterized protein Rv0628c/MT0656 should be stored at -20°C to -80°C upon receipt. The protein is typically supplied as a lyophilized powder in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0. When working with this protein, it is recommended to:

  • Centrifuge the vial briefly prior to opening

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% (50% is standard) for long-term storage

  • Aliquot the reconstituted protein to avoid repeated freeze-thaw cycles, which significantly reduce activity

  • Store working aliquots at 4°C for up to one week if immediate use is planned

This careful storage approach minimizes protein degradation and maintains structural integrity for experimental applications.

How should researchers approach the initial characterization of an uncharacterized protein like Rv0628c/MT0656?

Initial characterization should follow a systematic approach combining computational and experimental methods:

  • Bioinformatic analysis:

    • Sequence homology searches against characterized proteins

    • Structural prediction using tools like AlphaFold or I-TASSER

    • Domain and motif identification through databases such as Pfam and PROSITE

    • Phylogenetic analysis to identify evolutionary relationships

  • Basic biochemical characterization:

    • SDS-PAGE to confirm protein size and purity

    • Circular dichroism to assess secondary structure

    • Size exclusion chromatography to determine oligomeric state

    • Thermal shift assays to evaluate stability

  • Preliminary functional assays:

    • Protein-protein interaction screening (pull-downs, yeast two-hybrid)

    • Enzyme activity screening with diverse substrates

    • Cellular localization studies using tagged variants

This multi-faceted approach provides comprehensive baseline data while generating testable hypotheses about protein function. For uncharacterized proteins like Rv0628c/MT0656, applying in silico characterization methods has proven particularly valuable for predicting functional pathways and potential roles .

What strategies can improve the expression of Recombinant Uncharacterized protein Rv0628c/MT0656 in E. coli?

Optimizing expression of Rv0628c/MT0656 requires addressing several key factors that influence recombinant protein production:

  • Codon optimization:

    • The accessibility of translation initiation sites significantly impacts expression success

    • Tools like TIsigner can modify the first nine codons of mRNAs with synonymous substitutions to improve translation initiation

    • Higher accessibility leads to higher protein production, though it may slow cell growth due to resource allocation

  • Expression vector selection:

    • Vectors with tunable promoters allow optimization of expression levels

    • Consider testing multiple affinity tags beyond His-tag (GST, MBP) which may improve solubility

    • Inclusion of solubility-enhancing fusion partners may be beneficial

  • Culture conditions optimization:

    • Induction at lower temperatures (16-25°C) often improves folding

    • Testing various IPTG concentrations (0.1-1.0 mM)

    • Supplementing media with osmolytes or chaperone co-expression

A systematic approach testing these variables will maximize chances of successful expression. Data shows that approximately 50% of recombinant proteins fail to be expressed in host cells, making optimization critical for success .

What purification strategy is recommended for obtaining high-purity Rv0628c/MT0656 protein for structural studies?

A multi-step purification strategy is recommended to achieve the high purity (>95%) required for structural studies:

Purification StepMethodRationaleCritical Parameters
Initial captureIMAC (Ni-NTA)Leverages His-tag for selective bindingImidazole gradient: 20-250mM
Intermediate purificationIon exchange chromatographySeparates based on charge differencesBuffer pH should be 1-2 units from protein pI
PolishingSize exclusion chromatographyRemoves aggregates and provides buffer exchangeFlow rate ≤0.5 ml/min for optimal resolution
Quality controlSDS-PAGE and Western blotConfirms purity and identity≥95% purity required for structural studies

Additional considerations include:

  • Maintaining protein stability throughout purification by including protease inhibitors

  • Performing all steps at 4°C when possible

  • Testing buffer composition effects on stability using thermal shift assays

  • Considering on-column refolding if the protein forms inclusion bodies

This methodical approach maximizes both yield and quality of the target protein for downstream applications .

How can researchers design experiments to elucidate the function of uncharacterized proteins like Rv0628c/MT0656?

Designing experiments to determine the function of uncharacterized proteins requires a systematic approach:

  • Hypothesis generation through bioinformatics:

    • Sequence analysis to identify conserved domains and motifs

    • Structural prediction to identify potential binding sites or catalytic regions

    • Phylogenetic analysis to identify functional relationships with characterized proteins

  • Experimental design principles:

    • Begin with well-defined variables (independent: experimental conditions; dependent: functional readouts)

    • Develop specific, testable hypotheses based on predicted function

    • Design controls to account for potential confounding variables

    • Use both positive and negative controls for validation

    • Plan for technical and biological replicates

  • Functional validation approaches:

    • Gene knockout/knockdown studies to observe phenotypic changes

    • Protein-protein interaction studies (co-IP, crosslinking)

    • In vitro biochemical assays to test predicted enzymatic activities

    • Complementation studies in model organisms

This systematic approach enables researchers to progressively narrow down potential functions while building evidence for specific roles. For uncharacterized proteins like Rv0628c/MT0656, understanding the context of their genomic environment and expression patterns can provide additional clues to function .

What are the challenges in resolving potential data contradictions when characterizing uncharacterized proteins?

When characterizing uncharacterized proteins like Rv0628c/MT0656, researchers frequently encounter contradictory data that requires careful resolution:

  • Sources of contradictions:

    • Differences between in silico predictions and experimental results

    • Variation between in vitro and in vivo functional data

    • Context-dependent protein functions in different cellular environments

    • Technical variations between different experimental platforms

  • Resolution strategies:

    • Triangulate findings using multiple orthogonal methods

    • Perform dose-response and time-course experiments to identify condition-specific effects

    • Evaluate protein in its native context versus recombinant systems

    • Consider post-translational modifications that may be missing in recombinant systems

    • Examine protein-protein interactions that may modulate function

  • Statistical approaches:

    • Use appropriate statistical tests to determine significance of findings

    • Consider Bayesian approaches to integrate prior knowledge with new data

    • Meta-analysis techniques when multiple datasets are available

Contradictions often provide valuable insights into complex protein behaviors and should be viewed as opportunities to develop more sophisticated functional models rather than experimental failures .

How can in silico approaches be applied to predict functions of uncharacterized proteins like Rv0628c/MT0656?

Advanced computational methods offer powerful approaches for predicting functions of uncharacterized proteins:

  • Structural bioinformatics pipeline:

    • Ab initio structure prediction using AlphaFold2 or RoseTTAFold

    • Structure-based function prediction through pocket analysis and binding site identification

    • Molecular dynamics simulations to predict conformational flexibility

    • Virtual screening to identify potential ligands or interaction partners

  • Systems biology approaches:

    • Gene neighborhood analysis to identify functional associations

    • Co-expression network analysis to identify proteins with correlated expression

    • Protein-protein interaction network analysis to identify functional modules

    • Pathway enrichment analysis to identify potential biological processes

  • Machine learning integration:

    • Feature extraction from sequence, structure, and expression data

    • Supervised learning for function prediction based on known examples

    • Transfer learning from well-characterized protein families

For uncharacterized proteins like Rv0628c/MT0656, these computational approaches can generate focused hypotheses that significantly accelerate experimental characterization by narrowing the scope of potential functions to test experimentally . The in silico approach has proven particularly valuable for bacterial proteomes, where functional annotation of uncharacterized proteins can unveil novel functional pathways .

What role might Rv0628c/MT0656 play in microbial adaptation based on genomic and proteomic evidence?

Understanding the potential role of Rv0628c/MT0656 in microbial adaptation requires integrating multiple lines of evidence:

  • Genomic context analysis:

    • Presence in multiple strains suggests evolutionary conservation (identified in multiple C. difficile strains including BR81, R20291, CF5, M120, 196, and 2,007,855)

    • Syntenic relationships with neighboring genes may indicate functional relationships

    • Analysis of upstream regulatory regions for stress-responsive elements

  • Proteomic evidence:

    • Differential expression under varying environmental conditions

    • Post-translational modifications that may regulate activity

    • Interaction partners identified through proteome-wide studies

  • Structural features suggesting adaptive functions:

    • Analysis of the Rv0628c/MT0656 sequence reveals domains potentially involved in:

      • Nucleotide binding (suggesting possible regulatory functions)

      • Membrane association (suggesting potential role in cell envelope processes)

      • Protein-protein interaction motifs (suggesting involvement in signaling networks)

The integration of genomics, transcriptomics, and proteomics data has significantly advanced our understanding of microbial adaptation mechanisms. For uncharacterized proteins like Rv0628c/MT0656, these approaches can provide crucial insights into their potential roles in bacterial survival and adaptation to changing environments .

How can researchers design experiments to determine if Rv0628c/MT0656 interacts with other proteins in cellular pathways?

Designing robust experiments to identify protein-protein interactions requires a multi-faceted approach:

  • In vitro interaction studies:

    • Pull-down assays using purified Rv0628c/MT0656 as bait

    • Surface plasmon resonance to measure binding kinetics

    • Isothermal titration calorimetry for thermodynamic parameters

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

  • Cellular interaction studies:

    • Proximity labeling techniques (BioID, APEX) to identify neighbors in cellular context

    • Fluorescence resonance energy transfer (FRET) to detect direct interactions

    • Co-immunoprecipitation followed by mass spectrometry

    • Yeast two-hybrid or bacterial two-hybrid screening

  • Functional validation of interactions:

    • Mutagenesis of predicted interaction interfaces

    • Competition assays with peptides derived from interaction sites

    • Co-expression studies examining functional consequences of interaction

  • Data integration and network analysis:

    • Construction of protein interaction networks

    • Pathway enrichment analysis of identified interactors

    • Comparison with known interaction networks to identify novel connections

This systematic approach provides multiple lines of evidence for protein interactions while minimizing false positives. For uncharacterized proteins like Rv0628c/MT0656, identifying interaction partners often provides critical insights into potential functions .

What analytical techniques are most appropriate for confirming the structure and function of Rv0628c/MT0656?

A comprehensive analytical approach combines multiple techniques to elucidate structure and function:

Analytical TechniqueApplicationKey Information Obtained
X-ray crystallographyHigh-resolution structureAtomic-level details of protein structure
Cryo-electron microscopyStructure of complexesVisualization of protein in native-like states
Nuclear magnetic resonanceSolution structure and dynamicsConformational changes and flexibility
Circular dichroismSecondary structure analysisQuick assessment of folding and stability
Mass spectrometryProtein identification and PTMsExact mass and modifications
Hydrogen-deuterium exchangeConformational dynamicsSolvent-accessible regions
Surface plasmon resonanceBinding kineticsAssociation/dissociation rates
Isothermal titration calorimetryThermodynamics of bindingBinding energy and stoichiometry
Activity assaysFunctional characterizationEnzymatic activity or binding specificity

When working with uncharacterized proteins like Rv0628c/MT0656, it's advisable to begin with techniques that require less material (CD, mass spectrometry) before progressing to more material-intensive methods (crystallography, NMR). Integrating structural data with functional assays provides the most comprehensive characterization .

How should researchers approach troubleshooting expression issues with Rv0628c/MT0656?

Systematic troubleshooting of expression issues follows a logical progression through multiple variables:

  • Vector and construct design issues:

    • Verify sequence integrity through DNA sequencing

    • Assess mRNA secondary structure at translation initiation site

    • Consider synonymous codon modifications to improve accessibility of translation initiation sites

    • Test alternative affinity tags or fusion partners

  • Host strain considerations:

    • Test expression in multiple E. coli strains (BL21(DE3), Rosetta, Origami)

    • Consider strains with additional tRNAs for rare codons

    • Test strains with chaperone co-expression

  • Expression conditions optimization:

    • Temperature variation (16°C, 25°C, 30°C, 37°C)

    • IPTG concentration titration (0.1mM to 1.0mM)

    • Induction time optimization (2h, 4h, overnight)

    • Media formulation (LB, TB, auto-induction)

  • Solubility enhancement:

    • Addition of solubility enhancers (sorbitol, glycerol, salt)

    • Co-expression with molecular chaperones

    • Test detergent-assisted extraction if membrane-associated

For problematic proteins like Rv0628c/MT0656, focusing on translation initiation site accessibility has proven particularly effective, as research shows this factor significantly outperforms alternative features in predicting expression success. Tools like TIsigner can modify codons to improve accessibility and thereby enhance expression levels .

What are the most promising approaches for advancing understanding of uncharacterized proteins like Rv0628c/MT0656?

Future research on uncharacterized proteins should leverage emerging technologies and integrated approaches:

  • Advanced structural biology:

    • Integrating AlphaFold2 predictions with experimental validation

    • Time-resolved structural studies to capture conformational changes

    • Single-molecule techniques to examine structural heterogeneity

  • Systems-level characterization:

    • CRISPR-based genetic screens to identify functional pathways

    • Proteome-wide interaction mapping using proximity labeling

    • Metabolomics integration to connect protein function to cellular metabolism

  • Evolutionary analysis:

    • Ancestral sequence reconstruction to understand functional evolution

    • Comparative genomics across diverse species to identify conserved functions

    • Analysis of selective pressures to identify functionally important regions

  • Technology integration:

    • Machine learning approaches combining multiple data types

    • High-throughput automated experimental pipelines

    • Data-driven hypothesis generation and testing cycles

These integrated approaches promise to accelerate functional characterization of uncharacterized proteins like Rv0628c/MT0656, moving beyond traditional single-protein studies to understand their roles in broader biological contexts .

How can researchers leverage Rv0628c/MT0656 studies to advance understanding of related microbial systems?

Leveraging studies of Rv0628c/MT0656 for broader impacts requires strategic planning:

  • Comparative genomics approaches:

    • Identify homologs across multiple bacterial species

    • Compare genomic contexts to identify conserved gene neighborhoods

    • Analyze differential presence/absence patterns in pathogenic versus non-pathogenic strains

  • Translation to model systems:

    • Express homologs in model organisms to observe phenotypic effects

    • Create chimeric proteins to identify functionally conserved domains

    • Develop heterologous expression systems for functional screening

  • Application to biotechnology:

    • Explore potential enzymatic activities for industrial applications

    • Investigate as potential targets for antimicrobial development

    • Engineer modified variants with enhanced or novel functions

  • Database development and sharing:

    • Contribute structural and functional data to protein databases

    • Develop standardized protocols for characterization of related proteins

    • Create resources for comparative analysis across protein families

This knowledge transfer approach ensures that insights gained from studying Rv0628c/MT0656 contribute to broader understanding of microbial biology and potential applications in biotechnology and medicine .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.